-
1
-
-
25144441748
-
Molecular theory of cancer
-
10.4161/cbt.4.6.1818, 15970666
-
Blagosklonny MV. Molecular theory of cancer. Cancer Biol Ther 2005, 4:621-7. 10.4161/cbt.4.6.1818, 15970666.
-
(2005)
Cancer Biol Ther
, vol.4
, pp. 621-627
-
-
Blagosklonny, M.V.1
-
2
-
-
0034614637
-
The hallmarks of cancer
-
10.1016/S0092-8674(00)81683-9, 10647931
-
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
3
-
-
8144228952
-
Friends or foes - bipolar effects of the tumour stroma in cancer
-
10.1038/nrc1477, 15516957
-
Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4:839-49. 10.1038/nrc1477, 15516957.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 839-849
-
-
Mueller, M.M.1
Fusenig, N.E.2
-
4
-
-
33748601601
-
Evolution of cooperation among tumor cells
-
10.1073/pnas.0606053103, 1557388, 16938860
-
Axelrod R, Axelrod DE, Pienta KJ. Evolution of cooperation among tumor cells. Proc Natl Acad Sci USA 2006, 103:13474-9. 10.1073/pnas.0606053103, 1557388, 16938860.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 13474-13479
-
-
Axelrod, R.1
Axelrod, D.E.2
Pienta, K.J.3
-
5
-
-
43949138899
-
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
-
10.1016/j.ctrv.2008.01.007, 18367336
-
Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev 2008, 34:378-390. 10.1016/j.ctrv.2008.01.007, 18367336.
-
(2008)
Cancer Treat Rev
, vol.34
, pp. 378-390
-
-
Coley, H.M.1
-
6
-
-
0029789811
-
Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
-
Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 1996, 14:2197-205.
-
(1996)
J Clin Oncol
, vol.14
, pp. 2197-2205
-
-
Greenberg, P.A.1
Hortobagyi, G.N.2
Smith, T.L.3
Ziegler, L.D.4
Frye, D.K.5
Buzdar, A.U.6
-
7
-
-
7944225913
-
Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer
-
2409942, 15381937
-
Bonneterre J, Dieras V, Tubiana-Hulin M, Bougnoux P, Bonneterre ME, Delozier T, Mayer F, Culine S, Dohoulou N, Bendahmane B. Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer. Br J Cancer 2004, 91:1466-71. 2409942, 15381937.
-
(2004)
Br J Cancer
, vol.91
, pp. 1466-1471
-
-
Bonneterre, J.1
Dieras, V.2
Tubiana-Hulin, M.3
Bougnoux, P.4
Bonneterre, M.E.5
Delozier, T.6
Mayer, F.7
Culine, S.8
Dohoulou, N.9
Bendahmane, B.10
-
8
-
-
13644254794
-
Molecular mechanisms of drug resistance
-
10.1002/path.1706, 15641020
-
Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol 2005, 205:275-92. 10.1002/path.1706, 15641020.
-
(2005)
J Pathol
, vol.205
, pp. 275-292
-
-
Longley, D.B.1
Johnston, P.G.2
-
9
-
-
70349826431
-
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib
-
10.1016/j.drup.2009.07.001, 19648052
-
Broxterman HJ, Gotink KJ, Verheul HM. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug Resist Updat 2009, 12:114-26. 10.1016/j.drup.2009.07.001, 19648052.
-
(2009)
Drug Resist Updat
, vol.12
, pp. 114-126
-
-
Broxterman, H.J.1
Gotink, K.J.2
Verheul, H.M.3
-
10
-
-
0037988709
-
Pharmacogenomics of ABC transporters and its role in cancer chemotherapy
-
10.1016/S1368-7646(03)00005-0, 12729805
-
Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resistance Updates 2003, 6:71-84. 10.1016/S1368-7646(03)00005-0, 12729805.
-
(2003)
Drug Resistance Updates
, vol.6
, pp. 71-84
-
-
Sparreboom, A.1
Danesi, R.2
Ando, Y.3
Chan, J.4
Figg, W.D.5
-
11
-
-
0015461178
-
Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo
-
Dano K. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo. Cancer Chemother Rep 1972, 56:701-8.
-
(1972)
Cancer Chemother Rep
, vol.56
, pp. 701-708
-
-
Dano, K.1
-
12
-
-
33645830172
-
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
-
10.1016/0005-2736(76)90160-7, 990323
-
Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976, 455:152-62. 10.1016/0005-2736(76)90160-7, 990323.
-
(1976)
Biochim Biophys Acta
, vol.455
, pp. 152-162
-
-
Juliano, R.L.1
Ling, V.2
-
13
-
-
0030920342
-
Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance
-
10.1093/jnci/89.13.917, 9214671
-
Trock BJ, Leonessa F, Clarke R. Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst 1997, 89:917-31. 10.1093/jnci/89.13.917, 9214671.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 917-931
-
-
Trock, B.J.1
Leonessa, F.2
Clarke, R.3
-
14
-
-
0037362355
-
ATP binding cassette transporters and drug resistance in breast cancer
-
10.1677/erc.0.0100043, 12653670
-
Leonessa F, Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 2003, 10:43-73. 10.1677/erc.0.0100043, 12653670.
-
(2003)
Endocr Relat Cancer
, vol.10
, pp. 43-73
-
-
Leonessa, F.1
Clarke, R.2
-
15
-
-
9344264652
-
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity
-
Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Wahrer DC, Eekman CA, Schoester M, Lankelma J, Pinedo HM, Lowenberg B, et al. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood 1996, 87:4809-16.
-
(1996)
Blood
, vol.87
, pp. 4809-4816
-
-
Broxterman, H.J.1
Sonneveld, P.2
Feller, N.3
Ossenkoppele, G.J.4
Wahrer, D.C.5
Eekman, C.A.6
Schoester, M.7
Lankelma, J.8
Pinedo, H.M.9
Lowenberg, B.10
-
16
-
-
0036902448
-
Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines
-
10.1139/y02-132, 12489924
-
Meesungnoen J, Jay-Gerin JP, Mankhetkorn S. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines. Can J Physiol Pharmacol 2002, 80:1054-63. 10.1139/y02-132, 12489924.
-
(2002)
Can J Physiol Pharmacol
, vol.80
, pp. 1054-1063
-
-
Meesungnoen, J.1
Jay-Gerin, J.P.2
Mankhetkorn, S.3
-
17
-
-
0029131093
-
Prognostic relevance of P-glycoprotein expression in breast cancer
-
Linn SC, Giaccone G, van Diest PJ, Blokhuis WM, van der Valk P, van Kalken CK, Kuiper CM, Pinedo HM, Baak JP. Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol 1995, 6:679-85.
-
(1995)
Ann Oncol
, vol.6
, pp. 679-685
-
-
Linn, S.C.1
Giaccone, G.2
van Diest, P.J.3
Blokhuis, W.M.4
van der Valk, P.5
van Kalken, C.K.6
Kuiper, C.M.7
Pinedo, H.M.8
Baak, J.P.9
-
18
-
-
0026052463
-
Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro
-
10.1002/ijc.2910490427, 1917165
-
Licht T, Fiebig HH, Bross KJ, Herrmann F, Berger DP, Shoemaker R, Mertelsmann R. Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro. Int J Cancer 1991, 49:630-7. 10.1002/ijc.2910490427, 1917165.
-
(1991)
Int J Cancer
, vol.49
, pp. 630-637
-
-
Licht, T.1
Fiebig, H.H.2
Bross, K.J.3
Herrmann, F.4
Berger, D.P.5
Shoemaker, R.6
Mertelsmann, R.7
-
19
-
-
0029017629
-
Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line
-
10.1038/bjc.1995.180, 2033794, 7734315
-
Hu XF, Slater A, Wall DM, Kantharidis P, Parkin JD, Cowman A, Zalcberg JR. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. Br J Cancer 1995, 71:931-6. 10.1038/bjc.1995.180, 2033794, 7734315.
-
(1995)
Br J Cancer
, vol.71
, pp. 931-936
-
-
Hu, X.F.1
Slater, A.2
Wall, D.M.3
Kantharidis, P.4
Parkin, J.D.5
Cowman, A.6
Zalcberg, J.R.7
-
20
-
-
0033868114
-
Induction of P-glycoprotein expression on the plasma membrane of human melanoma cells
-
Molinari A, Toccacieli L, Calcabrini A, Diociaiuti M, Cianfriglia M, Arancia G. Induction of P-glycoprotein expression on the plasma membrane of human melanoma cells. Anticancer Res 2000, 20:2691-6.
-
(2000)
Anticancer Res
, vol.20
, pp. 2691-2696
-
-
Molinari, A.1
Toccacieli, L.2
Calcabrini, A.3
Diociaiuti, M.4
Cianfriglia, M.5
Arancia, G.6
-
21
-
-
33645109974
-
Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs
-
Pesic M, Markovic JZ, Jankovic D, Kanazir S, Markovic ID, Rakic L, Ruzdijic S. Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs. J Chemother 2006, 18:66-73.
-
(2006)
J Chemother
, vol.18
, pp. 66-73
-
-
Pesic, M.1
Markovic, J.Z.2
Jankovic, D.3
Kanazir, S.4
Markovic, I.D.5
Rakic, L.6
Ruzdijic, S.7
-
22
-
-
20044395654
-
P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model
-
10.1007/s11095-005-2585-8, 15906164
-
Luu KT, Uchizono JA. P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model. Pharm Res 2005, 22:710-5. 10.1007/s11095-005-2585-8, 15906164.
-
(2005)
Pharm Res
, vol.22
, pp. 710-715
-
-
Luu, K.T.1
Uchizono, J.A.2
-
23
-
-
13844306481
-
Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells
-
10.1073/pnas.0401851102, 545583, 15671173
-
Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelain M, Larson SM. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci USA 2005, 102:1933-8. 10.1073/pnas.0401851102, 545583, 15671173.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 1933-1938
-
-
Levchenko, A.1
Mehta, B.M.2
Niu, X.3
Kang, G.4
Villafania, L.5
Way, D.6
Polycarpe, D.7
Sadelain, M.8
Larson, S.M.9
-
24
-
-
58049204446
-
Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours
-
10.1371/journal.pone.0003894, 2597737, 19079610
-
Rafii A, Mirshahi P, Poupot M, Faussat AM, Simon A, Ducros E, Mery E, Couderc B, Lis R, Capdet J, et al. Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS ONE 2008, 3:e3894. 10.1371/journal.pone.0003894, 2597737, 19079610.
-
(2008)
PLoS ONE
, vol.3
-
-
Rafii, A.1
Mirshahi, P.2
Poupot, M.3
Faussat, A.M.4
Simon, A.5
Ducros, E.6
Mery, E.7
Couderc, B.8
Lis, R.9
Capdet, J.10
-
25
-
-
70349306861
-
Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
-
10.1038/leu.2009.76, 19369960
-
Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau GE. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 2009, 23:1643-9. 10.1038/leu.2009.76, 19369960.
-
(2009)
Leukemia
, vol.23
, pp. 1643-1649
-
-
Bebawy, M.1
Combes, V.2
Lee, E.3
Jaiswal, R.4
Gong, J.5
Bonhoure, A.6
Grau, G.E.7
-
26
-
-
67649363646
-
Analysis of a model for transfer phenomena in biological populations
-
Hinow P, Le Foll F, Magal P, Webb GF. Analysis of a model for transfer phenomena in biological populations. SIAM Journal of applied mathematics 2009, 70:40-62.
-
(2009)
SIAM Journal of applied mathematics
, vol.70
, pp. 40-62
-
-
Hinow, P.1
Le Foll, F.2
Magal, P.3
Webb, G.F.4
-
27
-
-
79951553569
-
Tunneling nanotubes and microparticles as concurrent carriers for cell-to-cell P-glycopretein transfers: evidence for extragenetic acquired resistance in breast cancer cells
-
Rouen
-
Pasquier J, Galas L, Boulangé-Leconte C, Bultelle F, Magal P, Webb GF, Le Foll F. Tunneling nanotubes and microparticles as concurrent carriers for cell-to-cell P-glycopretein transfers: evidence for extragenetic acquired resistance in breast cancer cells. Workshop: progress in cellular imaging 2010, Rouen.
-
(2010)
Workshop: progress in cellular imaging
-
-
Pasquier, J.1
Galas, L.2
Boulangé-Leconte, C.3
Bultelle, F.4
Magal, P.5
Webb, G.F.6
Le Foll, F.7
-
28
-
-
23044462180
-
Regulation of volume-sensitive Cl- channels in multi-drug resistant MCF7 cells
-
10.1016/j.bbrc.2005.07.010, 16039989
-
Marin M, Poret A, Maillet G, Leboulenger F, Le Foll F. Regulation of volume-sensitive Cl- channels in multi-drug resistant MCF7 cells. Biochem Biophys Res Commun 2005, 334:1266-78. 10.1016/j.bbrc.2005.07.010, 16039989.
-
(2005)
Biochem Biophys Res Commun
, vol.334
, pp. 1266-1278
-
-
Marin, M.1
Poret, A.2
Maillet, G.3
Leboulenger, F.4
Le Foll, F.5
-
29
-
-
0033167084
-
The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2
-
10.1006/abbi.1999.1221, 10375401
-
Zhou Y, Gottesman MM, Pastan I. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2. Arch Biochem Biophys 1999, 367:74-80. 10.1006/abbi.1999.1221, 10375401.
-
(1999)
Arch Biochem Biophys
, vol.367
, pp. 74-80
-
-
Zhou, Y.1
Gottesman, M.M.2
Pastan, I.3
-
31
-
-
33846215616
-
A primer on the mechanics of P-glycoprotein the multidrug transporter
-
10.1016/j.phrs.2006.10.007, 17095241
-
Hennessy M, Spiers JP. A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol Res 2007, 55:1-15. 10.1016/j.phrs.2006.10.007, 17095241.
-
(2007)
Pharmacol Res
, vol.55
, pp. 1-15
-
-
Hennessy, M.1
Spiers, J.P.2
-
32
-
-
8944261743
-
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations
-
Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996, 56:3010-20.
-
(1996)
Cancer Res
, vol.56
, pp. 3010-3020
-
-
Beck, W.T.1
Grogan, T.M.2
Willman, C.L.3
Cordon-Cardo, C.4
Parham, D.M.5
Kuttesch, J.F.6
Andreeff, M.7
Bates, S.E.8
Berard, C.W.9
Boyett, J.M.10
-
33
-
-
0035399830
-
Determining MDR1/P-glycoprotein expression in breast cancer
-
10.1002/1097-0215(20010701)93:1<114::AID-IJC1309>3.0.CO;2-J, 11391630
-
Faneyte IF, Kristel PM, van de Vijver MJ. Determining MDR1/P-glycoprotein expression in breast cancer. Int J Cancer 2001, 93:114-22. 10.1002/1097-0215(20010701)93:1<114::AID-IJC1309>3.0.CO;2-J, 11391630.
-
(2001)
Int J Cancer
, vol.93
, pp. 114-122
-
-
Faneyte, I.F.1
Kristel, P.M.2
van de Vijver, M.J.3
-
34
-
-
0025971364
-
Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine
-
10.1016/0277-5379(91)90476-T, 1673852
-
Sanfilippo O, Ronchi E, De Marco C, Di Fronzo G, Silvestrini R. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 1991, 27:155-8. 10.1016/0277-5379(91)90476-T, 1673852.
-
(1991)
Eur J Cancer
, vol.27
, pp. 155-158
-
-
Sanfilippo, O.1
Ronchi, E.2
De Marco, C.3
Di Fronzo, G.4
Silvestrini, R.5
-
35
-
-
0032887812
-
Clinical significance of P-glycoprotein expression in breast cancer
-
Li EX, Li R, Zhang ZH, Wang JB. Clinical significance of P-glycoprotein expression in breast cancer. Chinese Journal of Cancer Research 1999, 11:218-220.
-
(1999)
Chinese Journal of Cancer Research
, vol.11
, pp. 218-220
-
-
Li, E.X.1
Li, R.2
Zhang, Z.H.3
Wang, J.B.4
-
36
-
-
0033931737
-
Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer
-
10.1023/A:1006449931921, 10930086
-
Arnal M, Franco N, Fargeot P, Riedinger JM, Brunet-Lecomte P, Lizard-Nacol S. Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer. Breast Cancer Res Treat 2000, 61:13-20. 10.1023/A:1006449931921, 10930086.
-
(2000)
Breast Cancer Res Treat
, vol.61
, pp. 13-20
-
-
Arnal, M.1
Franco, N.2
Fargeot, P.3
Riedinger, J.M.4
Brunet-Lecomte, P.5
Lizard-Nacol, S.6
-
37
-
-
0034667390
-
Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance
-
Allen JD, Brinkhuis RF, van Deemter L, Wijnholds J, Schinkel AH. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res 2000, 60:5761-6.
-
(2000)
Cancer Res
, vol.60
, pp. 5761-5766
-
-
Allen, J.D.1
Brinkhuis, R.F.2
van Deemter, L.3
Wijnholds, J.4
Schinkel, A.H.5
-
38
-
-
0026465461
-
Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes
-
Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1992, 80:2735-9.
-
(1992)
Blood
, vol.80
, pp. 2735-2739
-
-
Chaudhary, P.M.1
Mechetner, E.B.2
Roninson, I.B.3
-
39
-
-
0030021362
-
Quantitative determination of the MDR-related P-glycoprotein, Pgp 170, by a rapid flow cytometric technique
-
10.1002/(SICI)1097-0320(19960201)23:2<120::AID-CYTO5>3.0.CO;2-O, 8742170
-
Ferrand VL, Montero Julian FA, Chauvet MM, Hirn MH, Bourdeaux MJ. Quantitative determination of the MDR-related P-glycoprotein, Pgp 170, by a rapid flow cytometric technique. Cytometry 1996, 23:120-5. 10.1002/(SICI)1097-0320(19960201)23:2<120::AID-CYTO5>3.0.CO;2-O, 8742170.
-
(1996)
Cytometry
, vol.23
, pp. 120-125
-
-
Ferrand, V.L.1
Montero Julian, F.A.2
Chauvet, M.M.3
Hirn, M.H.4
Bourdeaux, M.J.5
-
40
-
-
33747856508
-
P-glycoprotein effect on the properties of its natural lipid environment probed by Raman spectroscopy and Langmuir-Blodgett technique
-
10.1016/j.febslet.2006.07.069, 16930597
-
Oleinikov VA, Fleury F, Ianoul A, Zaitsev S, Nabiev I. P-glycoprotein effect on the properties of its natural lipid environment probed by Raman spectroscopy and Langmuir-Blodgett technique. FEBS Lett 2006, 580:4953-8. 10.1016/j.febslet.2006.07.069, 16930597.
-
(2006)
FEBS Lett
, vol.580
, pp. 4953-4958
-
-
Oleinikov, V.A.1
Fleury, F.2
Ianoul, A.3
Zaitsev, S.4
Nabiev, I.5
-
41
-
-
33947518806
-
Invasive breast cancer
-
Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, et al. Invasive breast cancer. J Natl Compr Canc Netw 2007, 5:246-312.
-
(2007)
J Natl Compr Canc Netw
, vol.5
, pp. 246-312
-
-
Carlson, R.W.1
Anderson, B.O.2
Burstein, H.J.3
Carter, W.B.4
Edge, S.B.5
Farrar, W.B.6
Goldstein, L.J.7
Gradishar, W.J.8
Hayes, D.F.9
Hudis, C.A.10
-
42
-
-
0023488816
-
Doxorubicin distribution in human breast cancer
-
Rossi C, Gasparini G, Canobbio L, Galligioni E, Volpe R, Candiani E, Toffoli G, D'Incalci M. Doxorubicin distribution in human breast cancer. Cancer Treat Rep 1987, 71:1221-6.
-
(1987)
Cancer Treat Rep
, vol.71
, pp. 1221-1226
-
-
Rossi, C.1
Gasparini, G.2
Canobbio, L.3
Galligioni, E.4
Volpe, R.5
Candiani, E.6
Toffoli, G.7
D'Incalci, M.8
-
43
-
-
0023260608
-
Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion
-
10.1038/clpt.1987.92, 3581649
-
Speth PA, Linssen PC, Holdrinet RS, Haanen C. Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Clin Pharmacol Ther 1987, 41:661-5. 10.1038/clpt.1987.92, 3581649.
-
(1987)
Clin Pharmacol Ther
, vol.41
, pp. 661-665
-
-
Speth, P.A.1
Linssen, P.C.2
Holdrinet, R.S.3
Haanen, C.4
-
44
-
-
26444500499
-
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors
-
10.1158/1078-0432.CCR-05-0343, 16203786
-
Laginha KM, Verwoert S, Charrois GJ, Allen TM. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 2005, 11:6944-9. 10.1158/1078-0432.CCR-05-0343, 16203786.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6944-6949
-
-
Laginha, K.M.1
Verwoert, S.2
Charrois, G.J.3
Allen, T.M.4
|